GeraldHFriedlandMDFACP
Infectious Disease • New Haven, CTHIV/AIDS Medicine
Professor Emeritus of Medicine and Epidemiology and Public Health
Dr. Friedland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
135 College St
New Haven, CT 06510Phone+1 203-737-6133Fax+1 203-737-4050
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 1970 - 1972- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1968 - 1970
NYU Grossman School of MedicineResidency, Internal Medicine, 1967 - 1968- NYU Grossman School of MedicineInternship, Internal Medicine, 1964 - 1965
- New York University School of MedicineClass of 1964
Certifications & Licensure
CT State Medical License 1991 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- A Study of Azidothymidine Plus Methadone in Patients With AIDS and AIDS Related Complex (ARC)
- The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 Weeks
- The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsPrevalence and Correlates of Physical Inactivity Among Individuals with HIV During the First COVID-19 Wave: A Cross-sectional Survey.Dini Harsono, Yanhong Deng, Sangyun Chung, Lydia A Barakat, Gerald Friedland
AIDS and Behavior. 2024-05-01 - Differentiated service delivery framework for people with multidrug-resistant tuberculosis and HIV co-infection.Karl Reis, Allison Wolf, Rubeshan Perumal, Boitumelo Seepamore, Kevin Guzman
Journal of Acquired Immune Deficiency Syndromes. 2024-02-06 - Building an Infectious Disease Diversity, Equity, and Antiracism (ID2EA) Curriculum: A Single Center's Experience and Reflections.Shana E Gleeson, Heidi Zapata, Meghan E Bathgate, Brinda Emu, Jennifer Frederick
Clinical Infectious Diseases. 2023-09-11
Journal Articles
- Another Pandemic: Lessons from HIV can inform our COVID-19 responseEdelman E, Aoun-Barakat L, Villanueva M, Friedland G, AIDS and Behavior, 2020
Press Mentions
美国400专家致信彭斯 提出21条防疫权威建议（全文翻译）March 6th, 2020
Grant Support
- Drug Interactions In Substance Abusers With HIV InfectionNational Institute On Drug Abuse2008–2011
- New England Program For AIDS Clinical Trials-Proact (CpcNational Institute Of Allergy And Infectious Diseases2000–2006
- Pharmacokinetic Evaluation Of MethadoneNational Center For Research Resources1999–2001
- Methadone Effect Of Didanosine (Ddi,Videx) And Stavudine (D4t,Zerit)National Center For Research Resources1998–1999
- Phase II Study Of Virologic And Immunologic Effects Of ZDV And D4TNational Center For Research Resources1997
- Methadone Effects On AZT DispositionNational Center For Research Resources1997
- Glucocorticoid Function In Subjective/Behavioral/Neurochemical Effect Of CocaineNational Center For Research Resources1997
- AIDS Clinical TrialsNational Institute Of Allergy And Infectious Diseases1994–1996
- Adult AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1992–1993
- Natural History Of HTLV-III/LAV InfectionNational Institute On Drug Abuse1987–1990
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
